Oxidative alterations induced in vitro by the photodynamic reaction in doxorubicin-sensitive (LoVo) and -resistant (LoVoDX) colon adenocarcinoma cells

Experimental Biology and Medicine

Volumn 235, Issue 1, 2010, Pages 98-110

  Kulbacka, Julita ^a   Chwiłkowska, Agnieszka ^a   Bar, Julia ^a   Poła, Andrzej ^a   Banaś, Teresa ^a   Gamian, Andrzej ^a,b   Saczko, Jolanta ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Colon adenocarcinoma; Multidrug resistance; Oxidative stress; Photodynamic reaction

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; DOXORUBICIN; GLUTATHIONE TRANSFERASE P1; PHOTOFRIN; PHOTOSENSITIZING AGENT; REACTIVE OXYGEN METABOLITE; SECRETORY PHOSPHOLIPASE A2; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ARTICLE; CANCER CELL; COLON ADENOCARCINOMA; COLON CANCER; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIPID PEROXIDATION; OXIDATIVE STRESS; PHOTODYNAMIC THERAPY; PROTEIN EXPRESSION; ULTRAVIOLET IRRADIATION;

ADENOCARCINOMA; CELL LINE, TUMOR; COLONIC NEOPLASMS; DIHEMATOPORPHYRIN ETHER; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; GLUTATHIONE S-TRANSFERASE PI; GROUP II PHOSPHOLIPASES A2; HEMATOPORPHYRIN PHOTORADIATION; HUMANS; LIPID PEROXIDATION; OXIDATIVE STRESS; PHOTOSENSITIZING AGENTS; PROTEINS; SULFHYDRYL COMPOUNDS; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 76749124861     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2009.009162     Document Type: Article

References (39)

1. Zawacka-Pankau J, Krachulec J, Grulkowski I, Bielawski KP, Selivanova G. The p53-mediated cytotoxicity of photodynamic therapy of cancer: recent advances. Toxicol Appl Pharmacol 2008;232:487-97
2. Saczko J, Kulbacka J, Chwilkowska A, Pola A, Lugowski M, Marcinkowska A, Malarska A, Banas T. Cytosolic superoxide dismutase activity after photodynamic therapy, intracellular distribution of photofrin II and hypericin, and P-glycoprotein localization in human colon adenocarcinoma. Folia Histochem Cytobiol 2007;45:93-8
3. Shen XY, Zacal N, Singh G, Rainbow AJ. Alterations in mitochondrial and apoptosis-regulating gene expression in photodynamic therapy-resistant variants of HT29 colon carcinoma cells. Photochem Photobiol 2005;81:306-13
4. Sutoh I, Kohno H, Nakashima Y, Hishikawa Y, Tabara H, Tachibana M, Kubota H, Nagasue N. Concurent expressions of matallothionein, glutathioneS- tansferase-π, and P-glycoprotein in colorectal cancers. Dis Colon Rectum 2000;43:221-32
5. Wang HP, Hanlon JG, Rainbow AJ, Espiritu M, Singh G. Up-regulation of Hsp27 plays a role in the resistance of human colon carcinoma HT29 cells to photooxidative stress. Photochem Photobiol 2002;76:98-104
6. Pajak B, Orzechowski A. Złożony charakter niewraż liwości immunologicznej ludzkiego raka jelita grubego na niektóre cytokiny (TNF-alfa, interferony) na przykładzie linii komórkowej COLO 205. Mechanizm niewraż liwości - z uwzglȩdnieniem białek sygnałowych*. Postepy Hig Med Dosw (online) 2004;58:428-37
7. Filipitis M. Mechanisms of cancer: multidrug resistance. Drug Discov Today: Disease Mech 2004;1:229-34
8. Nomani H, Ghobadloo SM, Yaghmaei B, Rezvanie NA, Yaghmaei K. Glutathione S-transferases activity in patients with colorectal cancer. Clin Biochem 2005;38:621-4
9. Aliya S, Reddanna P, Thyagaraju K. Does glutathione S-transferase Pi (GST-Pi) a marker protein for cancer? Mol Cell Biochem 2003;253:319-27
10. Jalili A, Makowski M, Ś witaj T, Nowis N, Wilczyń ski GM, Wilczek E, Chora̧ż y-Massalska M, Radzikowska A, Maśliń ski W, Biały Ł, Sieńko J, Sieroń A, Adamek M, Basak G, Mróz P, Krasnodȩbski IW, Jakóbisiak M, Goła̧b J. Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells. Clin Cancer Res 2004;10:4498-508
11. Piek JJ, de Winter RJ. Type II secretory phospholipase A2: The emerging role of biochemical markers of plaque inflammation. Eur Heart J 2003;24:1804-6
12. Mounier C, Wendum D, Greenspan E, Flejou J-F, Rosenberg DW, Lambeau G. Distinct expression pattern of the full set of secreted phospholipases A2 in human colorectal adenocarcinomas: sPLA2-III as a biomarker candidate. Br J Cancer 2008;98:1-9
13. Huang P, Feng L, Oldham EA, Keating MJ, Plunkett W. Superoxide dismutase as a target for the selective killing of cancer cells. Nature 2000;407:390-5
14. Bartosz G. Druga twarz tlenu, Wolne rodniki w przyrodzie. In: Warszawa PWN, 2003;Part 4:343-93
15. Croce AC, Supino R, Lanza KS, Locatelli D, Baglioni P, Bottiroli G. Photosensitizer accumulation in spontaneous multidrug resistant cells: a comparative study with Rhodamine 123, Rose Bengal acetate and Photofrin®. Photochem Photobiol Sci 2002;1:71-8
16. Du H-Y, Olivo M, Tan BK-H, Bay B-H. Hypericin-mediated photodynamic therapy induces lipid peroxidation and necrosis in nasopharyngeal cancer. Int J Oncol 2003;23:1401-5
17. Castano AP, Demidova TN, Hamblin MR. Mechanisms in photodynamic therapy: part two - cellular, cell metabolism and modes of cell death. Photodiag Photodyn Ther 2005;2:1-23
18. Don AS, Hogg PJ. Mitochondria as cancer drugs targets. Trends Mol Med 2004;10:372-8
19. Hilf R. Mitochondria are targets of photodynamic therapy. J Bioenerg Biomembr 2007;39:85-9
20. Capella MAM, Capella LS. A light in multidrug resistance: photodynamic treatment of multidrug-resistant tumors. J Biomed Sci 2003;10:361-6
21. Guo WJ, Zhou GD, Wu HJ, Liu YQ, Wu RG, Zhang WD. Ultrastructural localization of glutathione S-transferase-pi in human colorectal cancer cells. World J Gastroenterol 2000;6:454-5
22. Volm M, Rittgen W. Cellular predictive factors for the drug response of lung cancer. Anticancer Res 2000;20:3449-58
23. Cieslak A, Szejnach J. Molekularne mechanizmy chemoopornosci w raku nerki. Wsp Onkol 2005;9:123-8
24. Moor ACE. Signaling pathways in cell death and survival after photodynamic therapy. J Photochem Photobiol B: Biol 2000;57:1-13
25. Murphy MP. Investigating mitochondrial radical production using targeted probes. Biochem Soc Transact 2004;32:1011-4
26. Marchal S, Bezdetnaya L, Guillemin F. Modality of cell death induced by Foscan-based photodynamic treatment in human colon adenocarcinoma cell line HT29. Biochemistry (Mosc) 2004;69:45-9
27. Leunig A, Staub F, Peters J, Heiman A, Csapo Ch, Kempski O, Goetz AE. Relation of early Photofrin® uptake to photodynamically induced phototoxicity and changes of cell volume in different cell lines. Eur J Cancer 1994;30A:78-83
28. Kessel D, Luo Y. Mitochondrial photodamage and PDT-induced apoptosis. J Photochem Photobiol B 1998;42:89-95
29. Bors W, Czapski G, Saran M. An expanded function for superoxide dismutase. Free Radic Res Commun 1991;12-13:411-7
30. Johnson SA, Pardini RS. Antioxidant enzyme response to hypericin in EMT6 mouse mammary carcinoma cells. Free Radic Biol Med 1998;24:817-26
31. Das H, Koizumi T, Sugimoto T, Yamaguchi S, Hasegawa K, Tenjin Y, Nishimura R. Induction of apoptosis and manganese super-oxide dismutase gene by photodynamic therapy in cervical carcinoma cell lines. Int J Clin Oncol 2000;5:91-103
32. Saczko J, Kulbacka J, Chwiłkowska A, Ługowski M, Banaś T. Levels of lipid peroxidation in A549 cells after PDT in vitro. Ann Acad Med Bialost 2004;49:82-4
33. Balcerzyk A, Bartosz G. Thiols are main determinants of total antioxidant capacity of cellular homogenates. Free Radic Res 2003;37:537-41
34. Visconti R, Grieco D. New insights on oxidative stress in cancer. Curr Opin Drug Discov Dev 2009;12:240-5
35. 2+ concentrations related to PDT-induced apoptosis in photosensitized human cancer cells. Cancer Lett 1998;128:205-10
36. Andreani M, Olivier JL, Berenbaum F, Raymondjean M, Bereziat G. Transcriptional regulation of inflammatory secreted phospholipases A2. Biochim Biophys Act 2000;1488:149-58
37. Laye JP, Gill JH. Phospholipase A2 expression in tumours: a target for therapeutic intervention? Drug Discov Today 2003;8:710-5
38. Giannattasio G, Lai Y, Granata F, Mounier CM, Nallan L, Oslund R, Leslie CC, Marone G, Lambeau G, Gelb MH, Triggiani M. Expression of phospholipases A(2) in primary human lung macrophages role of cytosolic phospholipase A(2)-alpha in arachidonic acid release and platelet activating factor synthesis. Biochim Biophys Acta 2009;1791:92-102
39. Jensen SS, Andresen TL, Davidsen J, Høyrup P, Shnyder SD, Bibby MC, Gill JH, Jørgensen K. Secretory phospholipase A2 as a tumor-specific trigger for targeted delivery of a novel class of liposomal prodrug anticancer etherlipids. Mol Cancer Ther 2004;3:1451-8